LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Drug Delivery Intarcia has developed advanced implant-based treatments for chronic diseases such as diabetes, indicating potential opportunities to collaborate or supply innovative medical devices and technologies to support their proprietary delivery systems.

Recent Asset Sale The sale of key assets to i2o Therapeutics suggests new strategic directions and possible gaps in the company's portfolio, presenting opportunities to offer complementary products or services to assist in their future development and commercialization efforts.

Funding and Growth Having secured over 1 billion dollars in private financing, Intarcia demonstrates strong investor confidence, and along with its revenue in the range of 50 to 100 million dollars, highlights potential for expansion into new markets or expansion of existing product lines.

Focus on Chronic Disease Dedicated to improving outcomes for chronic disease patients, particularly with metabolic disorders, presenting sales opportunities in patient management solutions, digital health tools, and supportive therapies aligned with their mission.

Tech-Driven Approach Utilizing a modern tech stack including Microsoft tools, analytics, and data management platforms, opening avenues to offer tailored software, data analytics, or cloud solutions that can enhance their research and operational efficiencies.

Similar companies to Intarcia Therapeutics, Inc.

Intarcia Therapeutics, Inc. Tech Stack

Intarcia Therapeutics, Inc. uses 8 technology products and services including Hyperion, Microsoft Intune, IQVIA, and more. Explore Intarcia Therapeutics, Inc.'s tech stack below.

  • Hyperion
    Corporate Performance Management
  • Microsoft Intune
    Enterprise Mobility Management
  • IQVIA
    Health Platform
  • Microsoft
    Miscellaneous
  • Microsoft Word
    Office Suites
  • Android
    Programming Languages
  • Minitab
    Visualisation Software
  • Google Analytics
    Web Analytics

Media & News

Intarcia Therapeutics, Inc.'s Email Address Formats

Intarcia Therapeutics, Inc. uses at least 1 format(s):
Intarcia Therapeutics, Inc. Email FormatsExamplePercentage
First.Last@intarcia.comJohn.Doe@intarcia.com
93%
FirstLast@intarcia.comJohnDoe@intarcia.com
3%
Last.First@intarcia.comDoe.John@intarcia.com
3%
F-Last@intarcia.comJ-Doe@intarcia.com
1%

Frequently Asked Questions

Where is Intarcia Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconIntarcia Therapeutics, Inc.'s main headquarters is located at Park Drive Suite 1300 Boston, Massachusetts United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Intarcia Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Intarcia Therapeutics, Inc.'s main corporate office by phone at
+1-510-782-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Intarcia Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconIntarcia Therapeutics, Inc.'s official website is intarcia.com and has social profiles on LinkedInCrunchbase.

What is Intarcia Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconIntarcia Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Intarcia Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of March 2026, Intarcia Therapeutics, Inc. has approximately 68 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Information Officer: A. P.Chief Information Officer: A. P.Chief Information Security Officer: N. N.. Explore Intarcia Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Intarcia Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconIntarcia Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Intarcia Therapeutics, Inc. use?

Minus sign iconPlus sign iconIntarcia Therapeutics, Inc.'s tech stack includes HyperionMicrosoft IntuneIQVIAMicrosoftMicrosoft WordAndroidMinitabGoogle Analytics.

What is Intarcia Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconIntarcia Therapeutics, Inc.'s email format typically follows the pattern of First.Last@intarcia.com. Find more Intarcia Therapeutics, Inc. email formats with LeadIQ.

When was Intarcia Therapeutics, Inc. founded?

Minus sign iconPlus sign iconIntarcia Therapeutics, Inc. was founded in 1997.

Intarcia Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking. 

We are committed to seeking better outcomes which compels us to ask questions that have not been asked before or remain unresolved. 

We are driven by a desire to create meaningful impact across business, health and society to ease the burden on people living with chronic diseases.

Intarcia is a rapidly emerging biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease. Our cross-disciplinary teams include forward-thinking scientists and entrepreneurs collaborating in a fast-paced environment redefining the future of medicine.

Section iconCompany Overview

Headquarters
Park Drive Suite 1300 Boston, Massachusetts United States
Phone number
+1-510-782-****
Website
intarcia.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1997
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $50M$100M

    Intarcia Therapeutics, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Intarcia Therapeutics, Inc.'s revenue is estimated to be in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    A. P.
    Chief Information Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. P.
    Chief Information Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. N.
    Chief Information Security Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. L.
    Vice President Head Program Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. P.
    Vice President Of Manufacturing
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    B. Y.
    Vice President, Pharmaceutical Sciences
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. K.
    Vice President, Pharmaceutical Sciences
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. Y.
    Vice President, Head Of Evidence Generation Analytics, Global Medical Affairs, Safety Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. L.
    Vice President Head Program Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. N.
    Vice President, Head Of Statistics, Programming, And Data Management
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.